[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cd4-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CD4 Gene",35,27,[8,16,23,29,36,42,48,54,60,66,72,79,85,91,97,103,110,116,122,128,134,140,146,152,158,164,170,175,182,188,194,200,206,212,219],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06197672","Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant",[12],"Phase 1","RECRUITING","2026-08-26T02:16:41.943926Z","2026-07-05T05:32:16.746249Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07308886","Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)",[20],"Phase 2","2026-08-26T02:17:16.980188Z","2026-07-05T05:32:16.676145Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07596888","IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study",[12],"2026-08-26T02:18:40.612983Z","2026-05-29T15:36:40.206651Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT07479797","Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy",[33],"Phase 3","2026-08-26T02:15:00.557154Z","2026-05-13T02:55:06.709986Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT05719441","A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission",[20],"2026-08-26T02:19:19.975067Z","2026-05-05T02:47:14.270472Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT03829540","CD4CAR for CD4+ Leukemia and Lymphoma",[12],"2026-08-26T02:16:16.995720Z","2026-05-05T02:43:29.465176Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04131413","HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia",[12],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:29.166339Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06071624","Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.",[12],"2026-08-26T02:16:16.169331Z","2026-05-05T02:43:28.825591Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05514899","Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV",[20],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:28.535287Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07217379","The DART DELIVER-02 Study",[12],"2026-08-03T02:44:37.443404Z","2026-05-05T02:43:27.962830Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":77,"content_modified":78},"NCT04139304","A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma",[76],"Early Phase 1","2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.918186Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06659952","HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients",[],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:26.986079Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT04499053","Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer",[20],"2026-08-26T02:18:06.247899Z","2026-05-05T02:43:26.753466Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06554717","Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV",[20],"2026-08-26T02:16:46.951087Z","2026-07-05T05:32:16.760081Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT05849038","Inflammation and Depression in People With HIV",[20],"2026-08-26T02:17:45.190188Z","2026-07-05T05:32:16.738310Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":108,"content_modified":109},"NCT06829238","Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use",[107],"Phase 4","2026-08-26T02:15:27.567165Z","2026-05-05T02:43:28.728322Z",{"nct_id":111,"title":112,"phases":113,"status":13,"updated_at":114,"content_modified":115},"NCT05488431","Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)",[20],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.714261Z",{"nct_id":117,"title":118,"phases":119,"status":13,"updated_at":120,"content_modified":121},"NCT04728893","Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)",[20],"2026-08-26T02:17:42.501124Z","2026-05-05T02:43:28.133797Z",{"nct_id":123,"title":124,"phases":125,"status":13,"updated_at":126,"content_modified":127},"NCT03125642","Auto Stem Cell Transplant for Lymphoma Patients",[20],"2026-08-26T02:16:13.426928Z","2026-05-05T02:43:26.753431Z",{"nct_id":129,"title":130,"phases":131,"status":13,"updated_at":132,"content_modified":133},"NCT05985642","Observational PIC Destination Cohort",[],"2026-08-26T02:17:14.343713Z","2026-05-13T02:55:06.399361Z",{"nct_id":135,"title":136,"phases":137,"status":13,"updated_at":138,"content_modified":139},"NCT05026138","Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.279881Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT05002751","Quantifying Radiation Induced Vaginal Stenosis",[],"2026-08-26T02:19:15.498463Z","2026-05-13T02:55:06.277850Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT00867269","Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia",[],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.065807Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT04301076","Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)",[12],"2026-08-26T02:16:08.402952Z","2026-07-19T19:36:05.132850Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":162,"content_modified":163},"NCT02840747","Tissue Repository: CTCL Collection Protocol",[],"2026-08-26T02:16:33.772093Z","2026-05-13T02:55:06.102573Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":168,"content_modified":169},"NCT05090267","The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study",[],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:28.711608Z",{"nct_id":171,"title":172,"phases":173,"status":13,"updated_at":95,"content_modified":174},"NCT04359186","SCOPE Analytic Treatment Interruption Protocol",[],"2026-05-05T02:43:27.608416Z",{"nct_id":176,"title":177,"phases":178,"status":179,"updated_at":180,"content_modified":181},"NCT04266275","Topical Curcumin for HPV Related Cervical Disease",[20],"NOT_YET_RECRUITING","2026-08-26T02:15:53.461103Z","2026-05-05T02:43:29.323897Z",{"nct_id":183,"title":184,"phases":185,"status":179,"updated_at":186,"content_modified":187},"NCT06949800","CASCADE 2002: PROTECT Study, \"PRObiotics to TrEat Anal preCancer Trial",[20],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:28.538353Z",{"nct_id":189,"title":190,"phases":191,"status":179,"updated_at":192,"content_modified":193},"NCT06987318","A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute\u002FEarly HIV-1 Infection",[12],"2026-08-26T02:17:33.807405Z","2026-05-05T02:43:27.830833Z",{"nct_id":195,"title":196,"phases":197,"status":179,"updated_at":198,"content_modified":199},"NCT07539454","Nirogacestat in Patients With Kaposi Sarcoma",[20],"2026-08-26T02:19:24.527214Z","2026-05-05T02:43:27.308500Z",{"nct_id":201,"title":202,"phases":203,"status":204,"updated_at":21,"content_modified":205},"NCT06908083","Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART",[12],"ENROLLING_BY_INVITATION","2026-06-16T05:54:07.841980Z",{"nct_id":207,"title":208,"phases":209,"status":204,"updated_at":210,"content_modified":211},"NCT06495593","Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis",[107],"2026-08-26T02:17:39.048487Z","2026-06-16T05:54:07.757786Z",{"nct_id":213,"title":214,"phases":215,"status":216,"updated_at":217,"content_modified":218},"NCT07287137","Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study",[107],"ACTIVE_NOT_RECRUITING","2026-08-03T02:14:05.338730Z","2026-05-05T02:43:28.368478Z",{"nct_id":220,"title":221,"phases":222,"status":216,"updated_at":223,"content_modified":224},"NCT04487041","Tfh Dysfunction in HIV and Aging",[107],"2026-08-03T03:02:05.931134Z","2026-05-05T02:43:29.029263Z"]